
Sign up to save your podcasts
Or
“The bar has gotten higher because science has gotten so much better,” John Maraganore says on the latest BioCentury Show. Reflecting on the capital markets and the state of innovation, the founder and former CEO of Alnylam painted a picture of a robust ecosystem fueled by sprawling innovation, where the higher scrutiny by investors will serve the industry well. In a broad-ranging conversation with Editor in Chief Simone Fishburn, Maraganore gives his views on the innovation and funding landscape, geopolitical issues facing the industry and the outlook for the next generation of leaders.
View full story: https://www.biocentury.com/article/652517
#biotech #biopharma #pharma #lifescience #investment #innovation
00:00 Intro
01:50 Innovation Today
09:00 Obesity
12:23 Building, Mentoring Biotechs
16:38 Capital & Competition
24:10 Industry Overhangs
4.6
1010 ratings
“The bar has gotten higher because science has gotten so much better,” John Maraganore says on the latest BioCentury Show. Reflecting on the capital markets and the state of innovation, the founder and former CEO of Alnylam painted a picture of a robust ecosystem fueled by sprawling innovation, where the higher scrutiny by investors will serve the industry well. In a broad-ranging conversation with Editor in Chief Simone Fishburn, Maraganore gives his views on the innovation and funding landscape, geopolitical issues facing the industry and the outlook for the next generation of leaders.
View full story: https://www.biocentury.com/article/652517
#biotech #biopharma #pharma #lifescience #investment #innovation
00:00 Intro
01:50 Innovation Today
09:00 Obesity
12:23 Building, Mentoring Biotechs
16:38 Capital & Competition
24:10 Industry Overhangs
4,358 Listeners
1,199 Listeners
431 Listeners
349 Listeners
2,317 Listeners
1,438 Listeners
217 Listeners
122 Listeners
318 Listeners
88 Listeners
29 Listeners
195 Listeners
147 Listeners
10 Listeners
51 Listeners